iniuva GmbH / UKE Hamburg
EN: Prof. Dr. med. Søren Gersting is CEO of iniuva GmbH and Professor of Paediatric Research at the UKE in Hamburg. His work combines rare genetic disorders, protein misfolding and pharmacological chaperones with AI-assisted drug discovery to make therapies for rare diseases available more quickly and precisely. DE: Prof. Dr. med. Søren Gersting ist CEO der iniuva GmbH und Professor für Pädiatrische Forschung am UKE Hamburg. Seine Arbeit verbindet seltene genetische Erkrankungen, Proteinfehlfaltung und pharmacological chaperones mit KI-gestützter Wirkstoffentwicklung, um Therapien für seltene Erkrankungen schneller und präziser zugänglich zu machen.
Let's talk about Emma: Years of symptoms, no clear diagnosis, and every appointment ending with “we’re not sure.” For people living with a rare disease, the hardest part is not just the illness itself, but the uncertainty: too little knowledge, too few experts, and too few treatm…
